115371 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21248)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3742)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21248)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115371)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cowper gland
    Book Section

    Chen, Y. B.
    In Zhou, M.; Netto, G. J.; Epstein, J. I. (Eds.) Uropathology. 2nd ed (2023)

    Fulltext@MSK | Save
  • Chronic inflammation of the prostate
    Book Section

    Chen, Y. B.
    In Zhou, M.; Netto, G. J.; Epstein, J. I. (Eds.) Uropathology. 2nd ed (2023)

    Fulltext@MSK | Save
  • Optimization of production for cell therapies
    Book Section

    Wang, X.; Rivière, I.
    In Jewett, A.; Fong, Y. (Eds.) NK Cells in Cancer Immunotherapy: Successes and Challenges (2023)

    Fulltext@MSK | Save
  • Immunotherapy using CAR T: What we have learned from trials and where we are heading
    Book Section

    Zhu, A.; Bellis, R.; Saini, J.; Fong, C.; Adusumilli, P. S.
    In Jewett, A.; Fong, Y. (Eds.) NK Cells in Cancer Immunotherapy: Successes and Challenges (2023)

    Fulltext@MSK | Save
  • Ocular findings in patients with histiocytosis
    Meeting Abstract

    Francis, J. H.; Reiner, A. S.; Canestraro, J.; Raajit, R.; Abramson, D. H.; Diamond, E. L.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • CAR-associated hemophagocytic lymphohistiocytosis (carHLH) is associated with pre-infusion inflammation and high disease burden and predicts poor outcomes following tisagenlecleucel in pediatric B-ALL
    Meeting Abstract

    McNerney, K. O.; Lim, S. S.; Ishikawa, K.; Dreyzin, A.; Vatsayan, A.; Chen, J. J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Philips, C.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical resistance associated with a rare MAP2K1 mutation in an adult patient with multi-system langerhanscell-histiocytosis (MS-LCH)
    Meeting Abstract

    Rösler, W.; Balabanov, S.; Bühler, M.; Clarenbach, C.; Diamond, E.; Honecker, F.; Manz, M.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Genomic analysis of patients across continental ancestry groups
    Meeting Abstract

    Carrot-Zhang, J.; New, J.; Xie, A.; Frampton, G.
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save